Total Funding
74
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
470625
Cetek is a biopharmaceutical company that engages in the discovery and development of novel cancer therapeutics.
Jason S. Martin: DirectorPast Role: Argonaut Private Equity, Co-Founder, President & Managing Director
James L. Waters: Chairman & Chief Executive Officer
About the Company
Cetek Corporation is a biopharmaceutical company that engages in the discovery and development of novel cancer therapeutics. Its products include CTK110, a small molecule that shows in vitro and initial in vivo anticancer activity; CTK-100144, which has potent activity in vitro biochemical and cell-based assays; and CTK-100147 small molecules with
highly selective and low nano-molar potency against the chymotrypsin.
Cetek Corporation also provides contract services and discovery collaborations for various targets and therapeutic areas. The company was founded in 1996 and is headquartered in Marlborough, Massachusetts.
